Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from JJ.

J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out

Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out.

Investors Business Daily

Buy the Dip in Johnson & Johnson and Its Near-3% Dividend Yield

Johnson & Johnson stock has fallen in seven straight weeks, trades at less than 15 times earnings and pays a near-3% dividend yield. Plus, support is nearby.

The Street

J&J Stock Jolted by NYSE Glitch, and Earnings Don’t Help. Check the Chart.

Johnson & Johnson stock has fallen in 10 straight sessions and was jolted by NYSE issues and the earnings report. Here's the trade.

The Street

From analysis to the latest developments in health,
read the most diverse news in one place.

How J&J's Mostly Defunct Covid Shot Still Managed To Hamper Sales; Danaher Dives

Covid vaccines took a major toll on Johnson & Johnson and Danaher early Tuesday, hitting J&J's fourth-quarter sales and Danaher's guidance.

Investors Business Daily

Employers use patient assistance programs to offset their own costs

Anna Sutton was shocked when she received a letter from her husband’s job-based health plan stating that Humira, an expensive drug used to treat her daughter’s juvenile arthritis, was now on a long list of medications considered “nonessential benefits.”

Tribune News Service

Johnson & Johnson Stock Can Fly if It Clears This Level

One resistance level is holding back a more notable rally in Johnson & Johnson stock.

The Street

Johnson & Johnson Notches Quarterly Beat, Outplaying Exchange-Rate Headwinds

Johnson & Johnson topped third-quarter expectations on Thursday despite exchange-rate challenges, but JNJ stock pared back gains.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

BeiGene Takes On Johnson & Johnson's Blockbuster Cancer Drug — And Wins

BeiGene stock catapulted Wednesday after the company's leukemia treatment beat out a blockbuster drug from Johnson & Johnson.

Investors Business Daily

Movement in the Tylenol murders: Law enforcement seeks to persuade prosecutors to act on ‘chargeable’ case

CHICAGO — As the 40th anniversary of the 1982 Tylenol murders approaches, investigators are working with prosecutors on a now-or-maybe-never effort to hold a longtime suspect responsible for the poisonings that killed seven people in the Chicago area, the Tribune has learned.

Chicago Tribune

J&J tried to block lawsuits from 40,000 cancer patients. A court wants answers

Critics say a legal maneuver by one of the world's wealthiest corporations could set a precedent, allowing non-bankrupt companies and rich individuals to avoid liability for wrongdoing.

WEKU

Johnson & Johnson Stock Has Major Support on the Chart

Johnson & Johnson affirmed its full-year outlook and announced a new $5 billion buyback. Should you be a buyer right now?

The Street

Bristol Myers Squibb, Bayer Stocks Hit The Deck On Blood Thinner Flops

Blood thinners produced by drug giants Bristol Myers and Bayer fell short of predictions, leading shares of both stocks down Monday.

Investors Business Daily

J&J continues to sell talc-based baby powder in India, despite discontinuing in U.S. and Canada

Company says India is part of global transition to cornstarch-based powder

The Hindu

Winslow Homer, Cézanne and Zaha Hadid: the best art and architecture of autumn 2022

The exhibition of the year is here, plus we have South Korean pop culture, a Sudanese women’s champion, decoded Egyptian hieroglyphs, Zaha Hadid’s ‘yonic stadium’ and a rare showing for the ‘American Turner’

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Covid Stocks Pfizer, Moderna, Novavax Face Their Next Challenge, And It's Worth Billions

The Biden administration is planning to stop paying for Covid vaccines and treatments, a move that could buoy some Covid stocks.

Benzinga

If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

The Street

Johnson & Johnson Stock: Here’s the Level to Buy, and It’s a Steal

Johnson & Johnson stock is hitting its lowest level since March. Here's where it's a steal of a deal.

Evening Standard

Johnson & Johnson to stop selling talc-based powder after cancer lawsuits

Lawsuits have claimed product contains asbestos and causes cancer which company denies

Get all your
news in one place.

100’s of premium titles.
One news app.

Reuters

South Africa reports first death causally linked to COVID vaccine

South Africa's health regulator reported on Thursday a causal link between the death of an individual and Johnson Johnson's (JJ) COVID-19 vaccine, the first time such a direct link has been made in the country.

Investors Business Daily

Stock Market Rally Breaks Higher; Tesla, Netflix, Snap, United Airlines Key Earnings: Weekly Review

The stock market rally gained steam, breaking above key levels. Tesla soared on earnings, but the Fed and a big week of results loom.

Manchester Evening News

Manchester's first vegan fish and chip shop forced to close

The owner has blamed rising fuel and stock costs, as well as the cost of living crisis in an emotional statement

Benzinga

Morning Brief: Top Financial Stories Dominating on Tuesday, June 7

Reuters

Benzinga

J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement

Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent Biosolutions, Inc. (NYSE: EBS).

Bangkok Post

US move affects Africa's vax drive

The US Food and Drug Administration's recent decision to limit the use of the Johnson & Johnson Covid-19 vaccine to adults who cannot or will not get another vaccine will have profound consequences for African countries. The FDA said its move reflected the risk that the vaccine might cause a…

Benzinga

Emergent Bio Says Johnson & Johnson Breached COVID-19 Vaccine Contract

Emergent BioSolutions Inc (NYSE: EBS) said Johnson & Johnson (NYSE: JNJ) had breached an agreement by failing to buy the company's minimum quantity of COVID-19 vaccines.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.